GENMAB A/S/S (OTCMKTS:GMXAY – Get Free Report)’s stock price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $21.23 and traded as low as $20.07. GENMAB A/S/S shares last traded at $20.21, with a volume of 1,813,091 shares trading hands.
GENMAB A/S/S Price Performance
The stock has a 50-day simple moving average of $21.23 and a 200-day simple moving average of $22.51.
GENMAB A/S/S Company Profile
Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer primarily in Denmark. The company markets DARZALEX, a human IgG1k monoclonal antibody for the treatment of patients with multiple myeloma (MM); and Arzerra, a human IgG1k monoclonal antibody for the treatment of chronic lymphocytic leukemia (CLL).
See Also
- Five stocks we like better than GENMAB A/S/S
- How to Invest in Small Cap Stocks
- 3 Undervalued Stocks You Can Buy at a Discount Now
- Industrial Products Stocks Investing
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- P/E Ratio Calculation: How to Assess Stocks
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for GENMAB A/S/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENMAB A/S/S and related companies with MarketBeat.com's FREE daily email newsletter.
